Elliot Fox

Working in Media & Engagement at Real Chemistry. Mainly here to track/share news relating to the healthcare sector, along with Boston sports

[Real Chemistry @RealChemistry_]

Big ideas in biotech.

Our client Roivant CEO Matt Gline (@gline) joins Dr. Behzad Aghazadeh of Avoro Capital to explore the forces shaping the future — FDA changes, global markets, and the strategies driving biotech forward.

Check it out 👇

[BiotechTV @BiotechTV]

𝐍𝐞𝐰 𝐒𝐡𝐨𝐰 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐦𝐞𝐧𝐭: Today BiotechTV is excited to announce our newest regular show - Off-Target Effects with @gline.

Matt will share his perspective on news, and interview other biotech leaders.

Visit the show's dedicated page: https://t.co/QmH9QszoP2

[BiotechTV @BiotechTV]

From Barcelona: In addition to presenting data at #ESMO24 positioning its PD1 as potentially the standard of care in a new indication, @Incyte thinks it has an important new drug in its CDK2 inhibitor. $INCY

Full video: https://t.co/x0ApMuCJ8T

[Elliot Fox @ElliotMFox]

@JohnCendpts Best of luck, John! Thinking of you and the family.

[Elliot Fox @ElliotMFox]

@MikeHuckman @ldtimmerman @DamonRunyon Best of luck, Mike!

[Elliot Fox @ElliotMFox]

You know #JPM24 is around the corner when you're based on the east coast, but these last few days (maybe weeks) you've had your computer/calendar on west coast time. See ya out there!

[Elliot Fox @ElliotMFox]

@jsrosenblum

[Elliot Fox @ElliotMFox]

@megtirrell @CNN Congrats, Meg!

[Elliot Fox @ElliotMFox]

@HoopsReference

[Andrew Dunn @AndrewE_Dunn]

While Merck makes a nearly $11B play into immunology w/ the $RXRX deal, Copenhagen's Genmab announced a smaller strategic deal entering immunology this year

CEO Jan van de Winkel told me $GMAB won't shy away from M&A oppty to grow its immunology biz:
https://t.co/2oVff2cFnZ

[CNBCOvertime @CNBCOvertime]

Goodbye @megtirrell and good luck in your next adventure. You will be missed here at @CNBC!!

@MorganLBrennan @jonfortt

[Live Oak Bank Pavilion at Riverfront Park @LiveOakBankPav]

✨JUST ANNOUNCED✨ @DerekAndSusan are bringing their #SummerTour2023 to @LiveOakBankPav #Wilmington on 9/7!

🎟️ Tickets on sale this Friday (4/14) at 10 am here: https://t.co/UyXQC3VyzT

⚡ Part of the Reeds Jewelers Concert Series
👀 Live Nation Pre-Sale Code: VINYL

[Elliot Fox @ElliotMFox]

@arsalanarif @FT @JohnCendpts Congrats to you and the entire crew over there! Very exciting.

[Elliot Fox @ElliotMFox]

@AGKootenay

[Elliot Fox @ElliotMFox]

Exciting times for $ESPR at #ACC23! Congrats!

[JoAnne Foody, MD, FACC, FAHA @FoodyMD]

Check out some of the media coverage of #CLEAROutcomes at #ACC23 📰🫀🥼
⬇️⬇️⬇️
https://t.co/K334Hoih4q @TIME

[Esperion Inc. @EsperionInc]

We will be kicking off #ACC23/WCC with the positive results of our unprecedented #CLEAROutcomes Trial which focused on significant, underserved populations unable to maximize or tolerate #statins. Learn more here and see what’s next for Esperion #CVD

[Brittany Pearson Rivoli, MBA @_brittpearson]

Our Business Resource Group, Evolve, hosted a panel today on “What I Wish I Knew” w/ senior leaders across @RealChemistry_ ! My favorite insight from the session was “be unique, not necessarily complete,” — @JennPaganelli

Helping emerging leaders learn & grow #EvolveAlways 💪🏼

[Elliot Fox @ElliotMFox]

@scooperpr @SFGate Meanwhile, in NC - we're expecting record highs. https://t.co/1i9TYcMGX6

[Elliot Fox @ElliotMFox]

@JaredSHopkins

[Jared S. Hopkins @JaredSHopkins]

Will 2023 be a busy year for pharma dealmaking? Pfizer, Merck and Novartis executives tell us they are on the hunt for acquisitions to add to their pipelines https://t.co/WGU0TpLVAU